Cargando…
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
Autores principales: | Yao, Jian, Hui, Jian-wen, Chen, Yan-jun, Luo, Dong-yang, Yan, Jiang-shu, Zhang, Yi-fan, Lan, Yuan-xiang, Yan, Xiu-rui, Wang, Zhi-hua, Fan, Heng, Xia, He-chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425283/ https://www.ncbi.nlm.nih.gov/pubmed/37138098 http://dx.doi.org/10.1038/s41417-023-00620-3 |
Ejemplares similares
-
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023) -
Effects of Lycium barbarum glycopeptide on renal and testicular injury induced by di(2-ethylhexyl) phthalate
por: Zhou, Xianling, et al.
Publicado: (2022) -
Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
por: Huang, Yichun, et al.
Publicado: (2022) -
Lycium barbarum glycopeptide alleviates neuroinflammation in spinal cord injury via modulating docosahexaenoic acid to inhibiting MAPKs/NF-kB and pyroptosis pathways
por: Jiang, Zhanfeng, et al.
Publicado: (2023) -
Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
por: Huang, Yichun, et al.
Publicado: (2022)